TRPC6 and hepatocellular carcinoma: Similarly, TRPC6 was induced by doxorubicin treatment in Huh7 and HepG2 hepatocellular carcinoma cells, therefore its inhibition enhanced doxorubicin-induced cell death [173], suggesting that high TRPC6 level is associated with chemoresistance in hepatocarcinoma cell lines.